INTERSTITIAL LUNG DISEASES
Clinical trials for INTERSTITIAL LUNG DISEASES explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASES trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill may slow lung decline in scarring lung disease
Disease control Not yet recruitingThis study tests a medicine called nerandomilast in adults with a type of lung scarring (fibrosing ILD) that is not IPF. The goal is to see if it can slow down worsening of lung function over a year. About 466 participants will receive either the drug or a placebo, and doctors wi…
Matched conditions: INTERSTITIAL LUNG DISEASES
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
Lung fluid test may sharpen diagnosis of scarring lung diseases
Knowledge-focused Not yet recruitingThis study looks at how analyzing fluid from the lungs (called bronchoalveolar lavage) can help doctors tell different types of interstitial lung diseases apart. About 66 adults with suspected ILD will undergo a bronchoscopy to collect this fluid. The goal is to see if the types …
Matched conditions: INTERSTITIAL LUNG DISEASES
Sponsor: Maha Ahmed Abd EL Gawad Mohammed Okasha • Aim: Knowledge-focused
Last updated May 01, 2026 15:59 UTC